Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Uncontrolled and Suspected Eosinophilic Asthma
Clinical Trial
NCT01412736Last updated: 12/4/2025
4151.T
Kyowa Kirin Co., Ltd.
